Abion Inc. logo — ABION, pioneering precision oncology in lung cancer and infe...

Abion Inc.

ABION, pioneering precision oncology in lung cancer and infectious disease solutions

Founded 2007 Korea South Korea South 23 employees Series Unknown Health Care, Pharmaceutical

General Information

Company Name Abion Inc.
Founded Year 2007
Location Korea South Korea South +1
Founders / Decision Makers
Team member
Employees 23
Industries Health Care, Pharmaceutical
Funding Stage Series Unknown
Social

Get notified when Abion Inc. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Abion Inc.

Abion Inc. is a Korean drug discovery company established in 2007 with a pioneering spirit, focusing on precision oncology in lung cancer and infectious disease solutions. The company is distinguished by its robust pipeline for drug candidates in preclinical stage, clinical phase 1 and phase 2, aimed at treating lung cancers and infectious diseases. Abion actively seeks research and clinical partnerships. The last investment, a Venture Round investment, took place on 01 January 2009 and involved Company K Partners, IMM Investment. With its innovative approach and a focus on critical medical needs, Abion presents an intriguing prospect for potential investors in the Health Care and Pharmaceutical industries. For more insights, the company's activities can be explored through its YouTube channel: Abion Youtube channel.

Taxonomy: Precision Oncology, Pharmaceutical Company, Companion Diagnostics, Drug Development, Global Clinical Development, Commercialization, Innovative Drugs, Anti-Cancer Drug, Anti-Viral Drug, Emergency Medicine, Biological Disasters, Medical Research, Healthcare Innovation, Global Market

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round •••••• 2
Investor Investor
01 Jan 2009

Abion Inc. Alternatives & Competitors

Abion Inc. vs

Leading the future of eye care with efficient drug repurposing and fast-tracked clinical advancement...

Series C
11-50 employees
Biotechnology, Health Care
Abion Inc. vs

Targeting Metabolic Reprogramming in Fibrosis and Oncology

Unknown
7 employees
Biopharma, Biotechnology
Abion Inc. vs

Pioneering transdermal drug delivery to enhance therapeutic outcomes for osteoporosis and other pept...

Series C
Biotechnology, Health Care

FAQ About Abion Inc.

ABION, pioneering precision oncology in lung cancer and infectious disease solutions
Abion Inc. was founded in 2007.
Abion Inc. is headquartered in Korea South.
Abion Inc. operates in the following industries: Health Care, Pharmaceutical.
Abion Inc. has approximately 23 employees.
Abion Inc. has completed 1 funding round. The latest funding stage is Series Unknown.
Top alternatives and competitors to Abion Inc. include Cloudbreak Therapeutics, ImmunoMet Therapeutics, Inc., TransPharma Medical, Renibus Therapeutics Inc, Ascelia Pharma AB. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Abion Inc. and Cloudbreak Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Abion Inc. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy